Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
- 1998-01-01
- Clinical Trial · n = 85
- Current medical research and opinion 14(3)
- J Breza
- O Dzurny
- A Borowka
- T Hanus
- R Petrik
- G Blane
- H Chadha-Boreham
- PubMed: 9787978
- DOI: 10.1185/03007999809113352
- High evidence
- Clinical
The changes in subjective scores, IPSS and QoL after the two-month treatment period were highly statistically significant with mean improvements of 40% and 31%, respectively.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 50 mg twice daily